PF-05089771
- Generic Name
- PF-05089771
- Drug Type
- Small Molecule
- Chemical Formula
- C18H12Cl2FN5O3S2
- CAS Number
- 1235403-62-9
- Unique Ingredient Identifier
- 25U4N985O2
- Background
PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee).
Efficacy Of PF-05089771 In Treating Postoperative Dental Pain
Phase 2
Completed
- Conditions
- Postoperative Dental Pain
- Interventions
- First Posted Date
- 2012-02-08
- Last Posted Date
- 2018-06-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 235
- Registration Number
- NCT01529346
- Locations
- 🇺🇸
Central Texas Oral Surgery Associates, Austin, Texas, United States
🇺🇸Premier Research Group Limited, Austin, Texas, United States
🇺🇸PPD Development, LP, Austin, Texas, United States
The Safety and Tolerability of PF-05089771 Will be Investigated in Healthy Subjects Over a 14 Day Dosing Period.
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2011-10-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 30
- Registration Number
- NCT01365637
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
A Single Dose Escalation Study In Healthy Volunteers To Determine The Pharmacokinetics, Safety And Tolerability Of PF-05089771 In Healthy Volunteers
- First Posted Date
- 2010-12-14
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 61
- Registration Number
- NCT01259882
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2010-07-20
- Last Posted Date
- 2010-08-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 40
- Registration Number
- NCT01165736
- Locations
- 🇬🇧
Pfizer Investigational Site, Edinburgh, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath